Mirati Therapeutics (MRTX) Tops Q4 EPS by 6c

Mirati Therapeutics (NASDAQ: MRTX) reported Q4 EPS of ($0.77), $0.06 better than the analyst estimate of ($0.83).

For earnings history and earnings-related data on Mirati Therapeutics (MRTX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49